Drug Shortage Report for PMS-NAPROXEN

Last updated on 2020-06-10 History
Report ID 6142
Drug Identification Number 02017237
Brand name PMS-NAPROXEN
Common or Proper name NAPROXEN
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) SUPPOSITORY
Route of administration RECTAL
Packaging size 30
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-04-12
Estimated end date Unknown
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments Product to be discontinued.
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-06-10 French Compare
v6 2020-06-10 English Compare
v5 2017-05-12 French Compare
v4 2017-05-12 English Compare
v3 2017-04-13 English Compare
v2 2017-04-07 French Compare
v1 2017-04-07 English Compare

Showing 1 to 7 of 7